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Plain English summary:
People with osteoarthritis desire high quality care, support and information.
However, the quality of care for people with OA in general practice is not routinely
collected. Quality Indicators can be used to benefit patients by measuring whether
minimum standards of quality care are being met from a patient perspective.
The aim of this study was to describe how a Research User Group (RUG) worked
alongside researchers to co-produce a set of self-reported quality indicators for
people with osteoarthritis when visiting their general practitioner or practice nurse
(primary care). These were required in the MOSAICS study, which developed and
evaluated a new model of supported self-management of OA to implement the
NICE quality standards for OA.
This article describes the public involvement in the MOSAICS study. This was 1) the
co-development by RUG members and researchers of an Osteoarthritis Quality
Indicators United Kingdom (OA QI (UK)) questionnaire for use in primary care, and 2)
the comparison of the OA QI (UK) with a similar questionnaire developed in Norway.
This study shows how important and effective a research user group can be in
working with researchers in developing quality care indicators for osteoarthritis for
use in a research study and, potentially, routine use in primary care. The questionnaire
is intended to benefit patients by enabling the assessment of the quality of primary
care for osteoarthritis from a patient’s perspective. The OA QI (UK) has been used to
examine differences in the quality of osteoarthritis care in four European countries.
Abstract:
Background
People with osteoarthritis (OA) desire high quality care, support and information
about OA. However, the quality of care for people with OA in general practice is
not routinely collected. Quality Indicators (QI) can be used to benefit patients by
measuring whether minimum standards of quality care (e.g. NICE quality standards) are
being met from a patient perspective. A Research User Group (RUG) worked with
researchers to co-produce a set of self-report, patient-generated QIs for OA. The QIs
were intended for use in the MOSAICS study, which developed and evaluated a
new model of supported self-management of OA to implement the NICE
guidelines. We report on 1) the co-development of the OA QI (UK) questionnaire
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for primary care; and 2) the comparison of the content of the OA QI (UK)
questionnaire with a parallel questionnaire developed in Norway for the
Musculoskeletal Pain in Ullensaker (MUST) study.
Methods
Researchers were invited to OA RUG meetings. Firstly, RUG members were asked
to consider factors important to patients consulting their general practitioner (GP)
for OA and then each person rated their five most important. RUG members then
discussed these in relation to a systematic review of OA QIs in order to form a list
of OA QIs from a patient perspective. RUG members suggested wording and
response options for a draft OA QI (UK) questionnaire to assess the QIs. Finally
RUG members commented on draft and final versions of the questionnaire and
how it compared with a translated Norwegian OA-QI questionnaire.
Results
RUG members (5 males, 5 females; aged 52–80 years) attended up to four meetings.
RUG members ranked 20 factors considered most important to patients consulting
their GP for joint pain. Following discussion, a list of eleven patient-reported QIs for
OA consultations were formed. RUG members then suggested the wording and
response options of 16 draft items – four QIs were split into two or more questionnaire
items to avoid multiple dimensions of care quality within a single item. On comparison
of this to the Norwegian OA-QI questionnaire, RUG members commented that both
questionnaires contained seven similar QIs. The RUG members and researchers agreed
to adopt the Norwegian OA-QI wording for four of these items. RUG members also
recommended adopting an additional seven items from the Norwegian OA-QI with
some minor word changes to improve their suitability for patients in the UK. One
other item from the draft OA QI (UK) questionnaire was retained and eight items
were excluded, resulting in a 15-item final version.
Conclusions
This study describes the development of patient-reported quality indicators for OA
primary care derived by members of a RUG group, working in partnership with the
research team throughout the study. The OA QI (UK) supports the NICE quality
standards for OA and they have been successfully used to assess the quality of OA
consultations in primary care in the MOSAICS study. The OA QI (UK) has the potential
for routine use in primary care to assess the quality of OA care provided to patients.
Ongoing research using both the UK and Norwegian OA-QI questionnaires is
assessing the self-reported quality of OA care in different European populations.
Keywords: Osteoarthritis, Quality indicator, Patient-reported, Patient and public
involvement, Primary care, Impact
Background
Osteoarthritis (OA) is a leading cause of joint pain and years lived with disability
worldwide causing considerable detrimental impact on daily activities and quality of
life [1–4]. OA is one of the main reasons for musculoskeletal consultations with a
general practitioner by older adults [5].
High quality care is described as clinically effective, personal and safe, which is delivered
to all users of a health service in all aspects of care [6]. However, previous studies have
shown that the quality of care provided to patients with OA in primary care is suboptimal
[7–11] and varies according to patient age and OA severity [12]. Research has shown that
patients with OA need more information and education about the condition, diet, exer-
cise, aids, and better support for self-management [13]. However, core recommended
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treatments such as exercise, weight loss and the provision of written information is under-
used for patients with OA [7]. Furthermore many core treatment are initiated by the pa-
tients themselves rather than doctor initiated [7, 14].
Several international guidelines exist which provide recommendations for the man-
agement of OA [3, 4, 15, 16]. International quality standards for OA have also been
developed such as those recently published by the National Institute for Health &
Care Excellence (NICE) [17], and the European Musculoskeletal Conditions Surveil-
lance and Information Network (eumusc.net) [18]. Yet there are no robust or rou-
tinely collected measures used currently in general practice to monitor the quality of
care for people with OA [19], although an OA e-template for use during consultations
in primary care has recently been developed and tested [20, 21].
Quality indicators (QI) are ‘specific and measurable elements of practice that can be
used to assess the quality of care’ [22]. They are used to assess care quality according
to defined standards of care (e.g. NICE [17], eumusc.net [18]). QIs typically assess the
processes of care given to patients [23] by measuring what the provider can offer
patients and examining whether standards of care are being implemented.
A systematic review identified 15 QIs which are broadly applicable with current inter-
national guidance for the assessment of non-pharmacological and pharmacological
management of OA in primary care [8]; however the authors recommended an in-
creased use of QIs in primary care from the patient perspective.
The Management of OSteoArthritis In ConsultationS (MOSAICS) study [24] devel-
oped and evaluated a new model of supported self-management of OA to implement
the NICE guidelines for OA in primary care [3]. The MOSAICS study aimed to evalu-
ate the new model of supported self-management for OA in primary care, in terms of
the quality of care from both a clinical and a patient perspective (see Additional file 1
for more information about the MOSAICS study). The findings of the MOSAICS
study are subject to other papers in production. However, at the time of designing
the MOSAICS study, there was a lack of evidence regarding the experiences of pa-
tients with OA in primary care and there were few appropriate quality indicators that
captured the quality of primary care for OA from the patient perspective. Active and
meaningful patient and public involvement (PPI) is increasingly viewed and encour-
aged as integral part of the research process to improve its quality and relevance
[25–28]. Therefore the collaboration between the researchers and the RUG described
in this article led to development of patient reported QIs for the MOSAICS model of
self-support in primary care.
During the course of the MOSAICS study, the research team became aware of a
questionnaire capturing the patient perspective of the quality of OA primary care being
developed in Norway. The OsteoArthritis Quality Indicator (OA-QI) has since been
validated for use to measure the quality of primary care for OA in a Norwegian popula-
tion [29]. The Norwegian OA-QI, comprises 17 questions related to patient education
and information, regular provider assessments, referrals, and pharmacologic treatment.
The tool was developed by team of researchers and OA clinicians, with input from two
patient partners who gave feedback on the content of the finalised questionnaire. The
results of the validation study are reported elsewhere [29].
We report on the co-production of a set of self-report, RUG-generated QIs to cap-
ture the quality of primary care management of OA. We also compare the RUG-
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generated OA QI (UK) questionnaire with a Norwegian OA-QI questionnaire devel-
oped in parallel, leading to a final recommended OA QI (UK) questionnaire.
The manuscript was written using the Guidance for Reporting Involvement of Pa-
tients and Public (GRIPP) checklist for reporting Patient and Public Involvement
(PPI) in research [30]. This checklist provides a structure for improving the quality of
reporting of the PPI and is designed for studies that have included some form of pa-
tient and public involvement in research. The authors have referred to the checklist
to ensure all the relevant aspects of PPI in this study were reported.
PPI good practice
The PPI described in this article took place at the Arthritis Research UK Primary Care
Centre, Keele University. This institution takes an explicit and systematic approach to
involvement of patients and the public in research [31]. Formed in 2006, a Research
User Group (RUG) was established to embed PPI across the whole of the Centre’s re-
search activities and is supported by a dedicated PPI team and core funding. Cur-
rently, the RUG has over 60 members actively involved on over 60 projects, recruited
on a basis of ‘expertise by experience’ of musculoskeletal and other long term condi-
tions. Some RUG members have more experience in involvement in research than
other members, though all provide the lay perspective of their health condition. Our
approach to patient involvement draws on previous experience [32–35] and recom-
mendations for the good practice of PPI [25, 30, 36, 37] so that RUG members can
provide meaningful contributions to the research process (see Additional file 2 for
more information about the RUG).
Our good practice principles include holding meetings in accessible venues at con-
venient times; allocated parking; meeting and greeting on arrival; training and support;
inclusion of regular breaks during meetings; payment for RUG members’ time and con-
tribution (if wanted); and reimbursement of expenses. Meetings between researchers
and RUG members are made actively ‘jargon-free’ and any technical terms are ex-
plained in plain English.
Methods
The MOSAICS study investigated whether a new way of supporting self-management,
delivered during an OA consultation in primary care, could offer a clinically practical
approach to implementing the core NICE recommendations [24]. We describe here the
development of the OA QI (UK) questionnaire by the RUG group for use in the MO-
SAICS study in Stage 1, the comparison of this with a Norwegian OA-QI questionnaire
in Stage 2, and review of the finalised OA QI (UK) questionnaire in Stage 3. Figure 1
provides an overview of the process.
Patient and public involvement in this study
In 2009, RUG members with OA were invited to form an OA PPI group to work in
partnership with researchers throughout the MOSAICS study, including the develop-
ment of patient-reported QIs, set within a wider five year programme of research into
OA [24, 38]. Furthermore, two members (AH: a former member of the wider Research
User group and now PPI Support Worker/Coordinator; and RT: Lay member of the
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OA Research User Group) have co-authored this article, including writing the plain
English and providing detailed comments on the manuscript prior to the final submission.
During the course of the MOSAICS study, members of the research team met
with RUG members to co-produce the OA QI (UK) questionnaire for use in the
MOSAICS study. The discussion meetings were facilitated by the Centre’s PPI Sup-
port Worker/Coordinator, the MOSAICS study Chief Investigator and a trial coord-
inator. The PPI Support Worker/Coordinator provided a key role by attend the
meetings with RUG members to provide assistance and support, prior, during and
after meetings. The MOSAICS study Chief Investigator (KD) has collaborated with
the RUG on numerous research studies and is currently the senior academic lead
for PPI in the Centre. All trial coordinators at the Centre have a responsibility for
ensuring PPI in their respective studies and have lots of experience of collaborating
with RUG members.
Discussion notes from the meetings were recorded on flip charts and in meeting mi-
nutes. Following each meeting, a summary of the outcomes and decisions written in
plain English was sent to the RUG members to acknowledge their contribution and ver-
ify that all views had been captured. RUG members were also given the opportunity for
further comment at the start of the next meeting.
It was not intended to formally evaluate the PPI interaction and the RUG members’
experience in the process. However, the impact of the RUG members is described in
this article in the form of the co-produced OA QI (UK) questionnaire for use in the
MOSAICS study.
(UK)
(UK)
Fig. 1 Overview of the stages of development of the OA QI
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Ethical approval for the PPI activities was not sought because the RUG members
were acting as specialist advisers, providing valuable knowledge and expertise based on
their experience of a health condition or public health concern and their involvement did
not raise any ethical concerns [39]. However, the full MOSAICS research programme was
approved by the North West 1 Research Ethics Committee, Cheshire, UK (REC reference:
10/H1017/76) [24].
Stage 1: development of the OA QI questionnaire
Members of the OA RUG group (n = 10) were invited to a series of four discussion
groups with the research team to develop the patient-reported QIs for patients with
OA treated in primary care. The discussion groups took place over a three year period
from 2009–2012. The objectives of the discussion groups were i) to understand the
aims of MOSAICS and roles and expectations of the RUG members, ii) to identify im-
portant and relevant quality indicators for patients with OA when consulting in pri-
mary care, and iii) to develop wording and response options for a self-report OA QI
(UK) questionnaire to assess the identified quality indicators (Fig. 1).
i) Understanding the aims of MOSAICS and roles and expectations of the RUG
members
In the first meeting, a plain English summary of the MOSAICS study was
introduced to set the context for the meetings and outline roles of the RUG
members.
ii) Identifying important and relevant quality indicators of OA in primary care
consultations from a patient’s perspective
During facilitated discussions, RUG members identified factors they considered to
be important to patients with OA consulting their general practitioner (GP) to
help identify potential QIs for OA consultations. Each RUG member then ranked
(1 to 5) the top five factors they considered the most important. Any factors not
selected as ‘most important’ by at least one RUG member were excluded from
further discussions.
The research team then presented RUG members with five QIs identified from
a previous systematic review [8] (Fig. 2). These QIs were selected on the basis
of their relevance for the MOSAICS model OA consultation of supported
self-management and were used to stimulate discussion within the RUG group.
The QIs included whether during GP consultations, patients have been offered
education and advice about their disease, exercise and weight loss, and offered
pain relief in the form of paracetamol and topical (skin applied) non-steroidal
anti-inflammatory drugs (NSAIDS). RUG members were asked to 1) consider
each QI alongside the initial list of important factors when consulting their GP
for OA and add other factors as necessary, and 2) suggest potential QIs and
questions which could capture the quality of care from a patient perspective.
iii)Developing the wording and response options for a self-report OA QI (UK)
questionnaire
Based on the list of important factors suggested by RUG members, an initial
set of patient-reported OA QIs were generated. From this list, wording for
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questionnaire items to assess the QIs were drafted for an OA QI (UK) question-
naire. Over a further two meetings, RUG members and the research team
worked together to refine and finalise the questions so they were suitable for
use in a research trial. (See Fig. 3 for an outline of the process). Feedback and
suggestions on the wording of the items and the scoring method (response
Fig. 2 Five quality indicators identified from a systematic review used to stimulate discussion with the
RUG members
Fig. 3 Overview of the OA QI (UK) questionnaire item development
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options) were given on documents mailed to the RUG members between
meetings.
Stage 2: comparison of the OA QI (UK) with the Norwegian OA-QI questionnaire
The RUG group and MOSAICS study team had not planned to test the measurement
(or psychometric) properties of the OA QI (UK) questionnaire. As mentioned earlier in
this article, a similar OA QI questionnaire was being developed for use in primary care
in Norway (the Norwegian OA-QI) [29].
In order to establish the measurement properties of the OA QI (UK) questionnaire,
the Norwegian developers (NO, KH) produced an English translation of a draft ver-
sion of the Norwegian OA-QI for item content and scoring comparison. RUG mem-
bers reviewed this and compared its content with the OA QI (UK) questionnaire
during the third meeting. Based on this comparison, RUG members suggested how
the OA QI (UK) questionnaire could be refined and modified to include items in the
validated Norwegian OA-QI. Where QIs in each questionnaire were similar, RUG
members considered the appropriateness of the wording used in the Norwegian OA-
QI for potential use.
Stage 3: review of the finalised OA QI (UK) questionnaire
During the last meeting, the RUG reviewed, commented and suggested refinements to
the OA QI (UK) questionnaire for primary care. RUG members were also asked to as-
sess the face validity of the questionnaire by commenting further on its appearance and
layout, ease of completion, and to identify anything ambiguous or difficult to under-
stand. The research team also compared the content of the OA QI (UK) questionnaire
with the other questionnaires and data collected in the MOSAICS to check for un-
necessary duplication.
Results
Patient and public involvement
All of the RUG members (males 5, females 5) had OA and were aged 52–80 years. Four
meetings were held during the three year period. All meetings were attended by be-
tween three and ten members.
Stage 1: development of the OA quality indicators
Identifying important and relevant quality indicators of OA in primary care consultations
from a patient’s perspective
RUG members initially discussed and identified 30 factors considered important and
relevant to patients consulting their GP for OA. From this list, RUG members chose 20
factors as ‘most important’ (Table 1), which were grouped into the following domains:
information about OA; information about treatment for OA; information about self-
management for OA; advice about using medications to relieve joint pain; information
about exercise and activities; referrals to activity or exercise programmes, and the qual-
ity of the consultation with the GP. These domains formed an initial list of seven
patient-reported QIs for OA consultations. Following the review of the five quality indi-
cators identified from a systematic review [8], an additional four QIs appropriate from
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Table 1 Selection of factors considered most important to patients with OA consulting their GP
Domain Factors ranked most important
to patients with OA consulting
their GP (top 5 on a 1-5 scale)
Frequency Draft Patient reported QIs for
OA (‘In the last 3 months…..’)
Number of
items in the
draft OA QI
(UK)
questionnaire
Information
about treatment
for OA
Want to know about risks
or side effects from
the treatments
6 You have received
information regarding
treatment for joint problem
from your surgery
1
Want to know about pain
management [medications]
4
Want to know about the
expectations of any possible
help, i.e. whether you need
an X-ray/pain clinic/operation/
investigations/scan/refer
to a consultant
1
Want to know about surgery
and also what to do when the
consultant/surgeon says
because of the cause there is
nothing they can do
1
Want to get pain down to a
level you can cope with
1
Information
about OA
What you want is an
exchange between the GP
and yourself
4 You have received
information about your joint
problem from your surgery
1
How OA will affect quality
of life
2
When you get more pain, you
go to the GP
2
Pain has gone – will it stay
that way?
1
Consultations are a
combination of medical and
patient expectations
1
Age means that OA is seen
as inevitable
1
Want to know if it’s a serious
condition
1
Information
about
selfmanagement
for OA
Want to know about
techniques to [self] manage
pain
2 You have received advice and
support on how you might
help yourself to manage or
deal with your joint problem
3
Advice about
using
medications to
relieve joint pain
How to best use anti-
inflammatory medications
1 You have been offered advice
about medications (to relieve
joint pain)
4
Advice about
exercise or
activities
Want to know about should
we be doing more or less
2 You have been offered
information or advice on
exercise or activity to help
with your joint problem
3
Referral to
exercise or
activity
programmes
Did certain things to help
with quality of life (e.g. went
to gym, go swimming)
3 You have been offered a
referral to an exercise or
activity programme for your
joint problem
1
Quality of the
consultation
The quality of consultation is
important so that you know
you shouldn’t just soldier on
[live with pain]
3 You are satisfied with the
overall quality of the
consultation with his/her GP
for OAa
0a
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a patient perspective (‘patient has received a follow-up review of his/her joint problem’;
‘patient has received a referral for physiotherapy’; ‘patient has received advice about
body weight and joint pain’, ‘patient has received a referral for weight loss services’) were
added. Therefore, 11 unique QIs were identified (Table 1).
Developing the wording and response options for a self-report OA QI (UK) questionnaire
Using the list of eleven self-reported QIs for OA consultations, RUG members suggested
questionnaire wording and response options to assess each QI. RUG members stated that
the 3-month recall period, as determined by the MOSAICS trial design, was an appropri-
ate period to have had at least one consultation with their GP for a joint problem. They
also suggested that the response options should be a simple 3-level response format for all
questions for the draft questionnaire: “Yes”, “No”, and “Don’t know”.
The RUG members’ suggestions were drafted into a questionnaire. Views of the over-
all quality of the consultation were captured in other parts of the MOSAICS study, so
this item was not included in the questionnaire. To avoid multiple dimensions of care
within a single question, one QI (advice about using medications to relieve joint pain)
was split into four questions, two QIs (information about self-management for OA; ad-
vice about exercise or activities) into three items, and one other QI (follow up review)
was split into two questions, respectively.
The resultant draft OA QI (UK) questionnaire comprised 16 items. In the second
group meeting, RUG members reviewed the draft questionnaire and worked with the
research team to refine its content. RUG members provided further comments on the
ease of understanding and relevance of the questions. They suggested wording for the
questionnaire instructions and changes to improve the clarity, specificity and order of
the questions. RUG members suggested changing the wording for the ‘don’t know’
Table 1 Selection of factors considered most important to patients with OA consulting their GP
(Continued)
Consultation to take a holistic
approach/to ask patient about
feelings and thoughts about
the problem*
2
Previous consultation was a
waste of time and I haven’t
been back
1
Don’t want to waste the GP’s
time
1
Additional QIs following the discussion of the five treatment scenarios
Follow up review - - You have been given a
follow-up review of your joint
problem
2
Referral to
physiotherapy
- - You have been offered a
referral for physiotherapy for
your joint problem
1
Advice about
body weight
- - You have received advice
about body weight and joint
pain
0b
Referral to
weight loss
services
- - You have received a referral
for weight loss services
0b
aQuestionnaire items not created for this QI as it was adequately captured elsewhere in the larger MOSAICS survey
bQuestionnaire items not created for these two QIs as they were initially captured elsewhere in the larger MOSAICS study
Blackburn et al. Research Involvement and Engagement  (2016) 2:5 Page 10 of 20
response option where relevant if the respondent could not remember, if they had not
received an aspect of care, or if the question was not applicable.
Stage 2: comparison of the OA QI (UK) with the Norwegian OA-QI questionnaire
After reviewing both questionnaires, RUG members suggested that the draft OA QI
(UK) questionnaire and the draft Norwegian OA-QI were similar. Seven items in the
draft OA QI (UK) questionnaire capturing six quality indicators: (information about
OA, information about treatment for OA, information about self-managing OA, advice
about exercise or activities for OA, referral to exercise or activity programmes for OA,
advice about the use of medications to relieve joint pain) used comparable wording to
those included in the draft Norwegian OA-QI (Table 2). Of these, RUG members and
the research team agreed to retain the wording used in the draft OA QI (UK) question-
naire for three items and adopt all or some of wording in the draft Norwegian OA-QI
for the other four items for the final questionnaire. Both questionnaires used similar
three-level response options.
RUG members recommended that a further seven items (capturing six QIs) included
in the Norwegian OA-QI were relevant and should be added to the UK questionnaire.
They suggested minor changes to wording to make them more appropriate for the UK
(Table 2). Three other items from the Norwegian OA-QI questionnaire (advice about
changing lifestyle; assessment of daily activities; assessment of pain) were captured else-
where in the MOSAICS study and therefore not required for the OA QI (UK) question-
naire. Nine items from the draft OA QI (UK) that were not present in the Norwegian
OA-QI were retained at this stage. Therefore, at the end of Stage 2, the draft version of
the OA QI (UK) questionnaire contained 23 items (Fig. 3).
Stage 3: review of the finalised OA QI (UK) questionnaire
The iterative process of redrafting and reviewing the questionnaire continued into the
fourth meeting until the RUG members and researchers agreed on the final draft ver-
sion. Along with subtle changes to item wording suggested by RUG members, the re-
search team and RUG members agreed to retain one item from the draft OA QI (UK)
(on support for self-managing OA). Eight items from the draft OA QI (UK) (support
from ‘surgery’ or other health care professionals to help you manage your joint problem;
follow up review received (2 items); current participation in exercise; exercise programme
suggested; referral for physiotherapy; advice about taking paracetamol received; advice
about taking capsaicin cream received) were either covered elsewhere in the MOSAICS
study [24], too generic or were too similar to other items (Table 2). Therefore, these
eight items were not included in the final 15-item OA QI (UK) questionnaire (see
Additional file 3). RUG members and researchers agreed that the length of the final
version of the questionnaire was appropriate to capture important quality indicators
of OA in primary care consultations from a patient’s perspective without overburden-
ing those who complete it.
Discussion
This study describes the development of patient-reported quality indicators question-
naire for the primary care of osteoarthritis, which were derived by members of a
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Table 2 Comparison of the draft OA QI (UK) and Norwegian OA-QI questionnaires
Quality Indicator Draft OA QI (UK) Draft Norwegian OA-QI
(first English translation)
Published Norwegian OA-QI
(tested for validity and reliability)a
RUG and research team’s
recommendations for final
OA QI (UK) (✓ = retain or
add; X = not required)
RUG and research team’s
recommendations
(Changes to wording
for final OA QI (UK))
Patient has received
information about OA
Have you been given any
information about your joint
problem(s) from your surgery?
Have you been informed about
how the disease naturally evolves?
Have you been given information
about how the disease usually
develops over time?
✓ Retain (with draft OA
QI (UK) wording and
‘written or verbal’
information included)
Patient has received
information about
treatment for OA
Have you been given any information
regarding treatment for your joint
problem(s) from your surgery?
Have you been informed about treatment? Have you been given information
about different treatment
alternatives?
✓ Retain (Adopt draft
Norwegian OA-QI
wording)
Patient has received
information about
self-managing OA
(advice)
Have you been given any advice
on how you might help yourself
to manage or deal with your
joint problem(s)?
Have you been informed about
self-management?
Have you been given information
about how you can live with
the disease?
✓ Retain (with draft OA
QI (UK) wording)
Patient has received
information about
self-managing OA
(support)
Have you been given any support
on how you might help yourself
to manage or deal with your
joint problem(s)?
- - ✓ Retain (with draft OA
QI (UK) wording)
Patient has received
information about
self-managing OA
(support)
Have you been given any support
from your ‘surgery’ or other health
care professionals e.g. physiotherapists
or occupational therapists to
help you manage your joint
problem(s)?
- - X Not required
Patient has received
a follow up review
Have you been given a follow
up review of your joint problem(s)
at least once?
- - X Not required
Patient has received
a follow up review
Have you been given a follow up
review of your joint problem(s) ever?
- - X Not required
Patient has received
advice about changing
lifestyle
- Have you been offered advice
about lifestyle change?
Have you been given information
about how you can change
your lifestyle?
X Not required
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Table 2 Comparison of the draft OA QI (UK) and Norwegian OA-QI questionnaires (Continued)
Patient has received
advice about exercise
or activities for OA
(current participation
in exercise)
Do you participate in any exercise? - - X Not required
Patient has received
advice about exercise
or activities for OA
Have you been offered information
or advice on exercise or physical
activity to help you with your joint
problem(s)?
Have you been informed about
the impact of muscle strengthening
or aerobic exercise programs?
Have you been given
information about the importance
of physical activity and exercise?
✓ Retain (with draft OA QI
(UK) wording but ‘muscle
strengthening’ included)
Patient has received
a referral to exercise
or activity programmes
for OA
Have you been offered a referral
for exercise or activity programme
for your joint problem(s) (e.g. tai chi,
swimming, keep fit)?
Have you been referred to services
for a directed or supervised
strengthening or aerobic exercise
programs?
Have you been referred to someone
who can advise you about physical
activity and exercise
(e.g. a physiotherapist)?
✓ Adopt draft Norwegian
OA-QI wording
Patient has received
referral about exercise
or activities for OA
(exercise programme
suggested)
Has an exercise or activity
programme been suggested to
help you manage with your
joint problem(s)?
- - X Not required
Patient has received
advice about body
weight and joint pain
- Have you been advised to lose
weight, if you are overweight
and obese?
If you are overweight, have
you been advised to lose weight?
✓ Adopt draft Norwegian
OA-QI wording
(‘if you are overweight’
removed)
Patient has received
a referral for weight
loss
- Have you been referred to
services for losing weight,
if you are overweight and obese?
If you are overweight, have you
been referred to someone who
can help you to lose weight?
✓ Adopt draft Norwegian
OA-QI wording (‘if you
are overweight’ removed
and examples of weight
loss services added)
Patient has received
a referral for an
assessment of
activities of daily
living
If you have had problems related
to activities of daily living, have
these problems been assessed
in the last year?
If you have had problems related to
daily activities, have these problems
been assessed by health personnel
in the last year?
X Not required
Blackburn
et
al.Research
Involvem
ent
and
Engagem
ent
 (2016) 2:5 
Page
13
of
20
Table 2 Comparison of the draft OA QI (UK) and Norwegian OA-QI questionnaires (Continued)
Patient has received
a referral for
physiotherapy
Have you been offered a referral
for physiotherapy for your
joint problem(s)?
X Not required
Patient has received
a referral for an
assessment for aids
for daily living
- If you have problems related to
other activities of daily living,
has your need for assistive devices
(e.g. splints, assistive technology
for cooking or personal hygiene)
been assessed?
If you have problems related to
other daily activities, has your need
different appliances and aids been
assessed (e.g. splints, assistive
technology for cooking or personal
hygiene, a special chair)?
✓ Adopt draft Norwegian
OA-QI wording (‘assistive
devices’ changed to
‘appliances and
aids to daily living’)
Patient has received
a referral for an
assessment for
walking aids
- If you have problems related to
walking, has your need for
ambulatory assistive devices
(e.g. stick, crutch, or walker)
been assessed?
If you have problems with walking,
has your need for a walking aid
been assessed (e.g. stick, crutch,
or walker)?
✓ Adopt draft Norwegian
OA-QI wording
(‘ambulatory assistive
devices’ changed to ‘a
walking aid’)
Patient has received
as assessment of
his/her pain
- If you have pain, has your
pain been assessed in the last year?
If you have pain, has it been
assessed in the past year?
X Not required
Patient has received
advice about the use
of medications to
relieve joint pain
Have you been offered advice by
your surgery about taking
paracetamol before taking other
tablets?
If you have pain, was paracetamol
the recommended pharmacological
therapy for your osteoarthritic pain?
If you have pain, was
acetaminophen the first medicine
that was recommend for your
osteoarthritic pain?
✓ Adopt draft Norwegian
OA-QI wording
(‘pharmacological’
and ‘osteoarthritic’
removed)
Patient has received
advice about the use
of medications to
relieve joint pain
Have you been offered advice by
your surgery about taking the
following medication: paracetamol?
- - X Not required
Patient has received
advice about the use
of medications to
relieve joint pain
(Recommendation
for stronger analgesia)
- If you have prolonged severe pain,
for which paracetamol does not
provide pain relief, have you been
offered stronger analgesic drugs
(e.g.,…)?
If you have prolonged severe pain,
which is not relieved sufficiently
by paracetamol, have you been
offered stronger pain killers
(e.g., coproxamol, co-dydramol,
tramadol, co-codamol,
dihydrocodeine,
codeine)?
✓ Adopt draft Norwegian
OA-QI wording
(‘analgesic’ changed to
‘painkilling’)
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Table 2 Comparison of the draft OA QI (UK) and Norwegian OA-QI questionnaires (Continued)
Patient has received
advice about the
use of medications
to relieve joint pain
(Anti-inflammatory
drug information)
Have you been offered advice by
your surgery about taking the
following medication: topical
anti-inflammatory creams or gels
(e.g. Votarol gel, diclofenac,
ibuprofen cream)?
If you use anti-inflammatory drugs
(e.g. …), have you received information
about the effects and potential side
effects associated with this drug?
If you are taking antiinflammatory
drugs, have you been given
information about the effects
and possible side effects of this
medicine (e.g., ibuprofen, Nurofen,
Brufen, diclofenac, Voltarol,
naproxen, Naprosyn, Celebrex)?
✓ Adopt draft Norwegian
OA-QI wording
Patient has received
advice about the use
of medications to
relieve joint pain
(capsaicin cream)
Have you been offered advice
by your surgery about taking
the following medication:
capsaicin cream?
- - X Not required
Patient has received
advice about the use
of medications to
relieve joint pain
(Consideration for
corticosteroid injection)
- If you have experienced an
acute deterioration in symptoms,
has a corticosteroid injection been
considered?
If you have experienced an acute
deterioration of your symptoms,
has a corticosteroid injection
been considered?
✓ Adopt draft Norwegian
OA-QI wording
Patient has been
considered for referral
for surgery
- If you experience severe symptomatic
osteoarthritis, and pharmacological
therapy and exercises have no
response, have you been referred
for evaluation of surgery (e.g.,
total joint replacement)?
If you are severely troubled
by your osteoarthritis, and
exercise and medicine
do not help, have you been
referred and assessed for an
operation (e.g., joint replacement)?
✓ Adopt draft Norwegian
OA-QI wording
aFinal wording of Norwegian OA-QI was published after the OA RUG group reviewed and compared the draft OA QI (UK) with the draft Norwegian OA-QI
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Research User Group, working in partnership with researchers. The OA QI (UK) has
been successfully used in a large randomized control trial of a new model of sup-
ported self-management of OA (the MOSAICS study) [22] and a study to audit the
quality of OA primary care practice in the United Kingdom, Norway, Denmark and
Portugal. While the full results of these studies are subject to other papers in produc-
tion, the focus of this article is on the role and impact of PPI to develop the OA QI
(UK).
The active, meaningful and on-going involvement of patients as partners in the research
process is a strength of this study. The perspectives of patients may differ from the per-
spectives of healthcare professionals or information recorded by professionals in medical
records [40, 41]. Therefore, the unique perspectives of patients with OA based on their
experience of the condition and past consultations in primary care has enhanced the de-
velopment of patient-centred quality indicators for use in OA primary care. We acknowl-
edged that the PPI input in this study incorporated the perspectives of a small group of
patients, as small as three people for one meeting. Also, the RUG membership was not
greatly diverse, in terms of age, ethnicity, and physical abilities. While obtaining a range of
perspectives is the objective of PPI in research and not necessarily ‘representativeness’, it is
possible however that the OA QI (UK) does not cover the full range of quality indicators
relevant to the population of patients with OA. Nevertheless, the sequential and iterative
development of the OA QI (UK) allowed the researchers and RUG members to review
and critique earlier suggestions made by the RUG.
The RUG group identified important factors related to the quality of OA care pro-
vided by a primary care healthcare professional and suggested item wording for a ques-
tionnaire. By comparing the OA QI (UK) questionnaire with a similar one developed in
Norway, the RUG members helped redraft and refine the final questionnaire. The RUG
collaborated with the research team throughout the development of the OA QI (UK)
but were also involved on other aspects of the MOSAICS study such as developing a self-
management guidebook for patients with OA and participant information sheets [33, 42]).
Regular meetings were set up for these. Though there were extended gaps between meet-
ings regarding the OA QI (UK) development, the timings of the meetings were governed
by the MOSAICS study timeline. However, RUG members were provided with feedback
of the meeting and given the opportunity to comment. This process built upon existing
working relationships and trust between the RUG and researchers.
The research team embraced the contribution of the RUG members and imple-
mented many of their suggestions. The concepts included in the finalised OA QI (UK)
were generated by the RUG members. Working in collaboration the RUG members
and the research team shaped the items in survey questions suitable for use in a re-
search trial. The Chief Investigator did not make decisions on the final content of the
questionnaire without the fully informed RUG and explained if information was already
captured elsewhere in the MOSAICS study. For example, RUG members did identify
eight other important and relevant QIs not included in the final version of the OA QI
(UK). So, to avoid repetition and participant burden in the MOSAICS study, these eight
items were not included in the final 15-item OA QI (UK) questionnaire. These deci-
sions were fully explained to the RUG members. Therefore, the RUG members' contri-
bution ensured that the resulting OA QI (UK) incorporated issues relevant to patients
with OA, written in a language that patients found easy to understand.
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The OA QI (UK) was developed to assess the uptake of treatment recommended by
NICE [3] and complements the new NICE Quality Standards of Care for OA [15].
Using evidence from a systematic review [8], the OA QI (UK) is a 15-item question-
naire that covers treatments offered by healthcare professionals in primary care. The
OA QI (UK) supports the recently published NICE Quality Standards of Care for OA
[17] and the European Musculoskeletal Conditions Surveillance and Information Net-
work (eumusc.net) recommendations for the OA Standards of Care across European
member states [43]. For example, it captures five of the eight NICE quality statements
either fully or partially from a patient’s viewpoint. The OA QI (UK) and the Norwegian
OA-QI also sit alongside established outcome measures of OA management and provide
process measures of the quality of OA care. The eumusc.net has developed OA
health care quality indicators (HCQI-OA) and an accompanying audit tool for clini-
cians and health care providers [44]. The OA QI (UK) and HCQI-OA both include
six similar quality indicators. This questionnaire, if used in routine practice, will
have the patients’ perspectives embedded in an evaluation of care quality. Though
developed for use across primary care settings, the OA QI (UK) may be further re-
fined to meet the specific needs and priorities of local health care settings, if
required.
Establishing the measurement properties of a questionnaire is an important step in
its development. The use of scientifically sound and decision-relevant measures al-
lows the collection of evidence on the benefits of intervention (or care practices) from
a patients’ perspective [45]. The OA QI (UK) and the Norwegian OA-QI were devel-
oped in parallel. Given the similarity between the construct and wording of the two
questionnaires and the direct additions of items from the Norwegian OA-QI, the UK
version ‘adopted’ the measurement properties of the validated Norwegian version.
The comparison of the questionnaires used a translated, draft version of the Norwe-
gian OA-QI. However, the Norwegian OA-QI was further refined with some changes
to the item wording before validity and reliability testing. Though they are very simi-
lar in content and wording, the finalised, validated Norwegian OA-QI was published
after the OA QI (UK) was produced and implemented in the MOSAICS study. The
measurement properties of the OA QI (UK) was not tested because the 14 (out of the
15 items) were identical or contained subtle changes in wording to items in the vali-
dated Norwegian questionnaire. Therefore, conducting a full validation study on the
OA QI (UK) questionnaire was not justified at this stage. However, the assumption
that the measurement properties of the two questionnaires are similar may need fur-
ther exploration.
The overall positive feedback from RUG members on the Norwegian OA-QI en-
abled adaptations to the OA QI (UK) to be made with confidence. The development
of the both questionnaires was coincidental. Although there was differences in how
they were developed (one mainly patient-led and the other mainly researcher/clinician
derived), this study has demonstrated that patients and researchers have similar ex-
pectations about what constitutes good quality care in OA in different European
countries. It also highlights the value of the active, meaningful and useful contribu-
tion of patients in the research process. Furthermore, the consistency of quality indi-
cators for OA consultations in two European countries has now provided a unique
opportunity to compare QIs across European countries [46]. This may lead to the
Blackburn et al. Research Involvement and Engagement  (2016) 2:5 Page 17 of 20
development of a single, combined questionnaire for use in routine clinical practice
to assess the quality of OA care provided to patients.
Conclusion
This study has demonstrated that active involvement of patients in research, working
in partnership with researchers, identified important and relevant OA quality indica-
tors, and developed a self-reported questionnaire to measure them. The OA QI (UK)
questionnaire aligns with current national and international standards and process
measures of OA care (e.g. NICE, eumusc.net) and is consistent with quality indicators
validated for Norwegian OA consultations. The development of two OA quality indica-
tor questionnaires was coincidental but has led to further research to compare patient-
reported OA QIs across European countries. Following this work, a single refined OA
QI questionnaire for use in routine clinical practice is planned.
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